Monte Rosa Therapeutics, Inc. vs Adaptimmune Therapeutics PLC, risk disclosures compared

2topics both disclose

8only Monte Rosa Therapeutics, Inc.

3only Adaptimmune Therapeutics PLC

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Monte Rosa Therapeutics, Inc.	Adaptimmune Therapeutics PLC
Internal Control	3	3
Records Retention	2	1

Only Monte Rosa Therapeutics, Inc.

Topic	Filings
Business Continuity	7
Audit Committee Oversight	6
ESG Reporting	2
Regulatory Investigation	2
Third Party Risk Management	2
AI Governance	1
Artificial Intelligence	1
Restatement	1

Only Adaptimmune Therapeutics PLC

Topic	Filings
Data Breach	4
Material Weakness	3
Enforcement Action	2

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Monte Rosa Therapeutics, Inc. · Adaptimmune Therapeutics PLC · All companies